Charles Schwab’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.04M Sell
332,394
-25,901
-7% -$215K ﹤0.01% 2716
2025
Q4
$2.98M Buy
358,295
+14,737
+4% +$159K ﹤0.01% 2638
2025
Q3
$5.01M Buy
343,558
+12,019
+4% +$144K ﹤0.01% 2444
2025
Q2
$3.73M Buy
331,539
+98,389
+42% +$762K ﹤0.01% 2457
2025
Q1
$1.33M Sell
233,150
-567
-0.2% -$5.78K ﹤0.01% 2743
2024
Q4
$2.3M Buy
233,717
+17,372
+8% +$149K ﹤0.01% 2633
2024
Q3
$1.76M Buy
216,345
+49,210
+29% +$493K ﹤0.01% 2746
2024
Q2
$2.23M Sell
167,135
-30,179
-15% -$900K ﹤0.01% 2677
2024
Q1
$9.16M Buy
197,314
+5,781
+3% +$299K ﹤0.01% 2029
2023
Q4
$12.9M Buy
191,533
+6,073
+3% +$372K ﹤0.01% 1857
2023
Q3
$13.4M Buy
185,460
+38,852
+27% +$3.11M ﹤0.01% 1753
2023
Q2
$10.9M Buy
146,608
+12,862
+10% +$761K ﹤0.01% 1876
2023
Q1
$7.12M Buy
133,746
+15,638
+13% +$991K ﹤0.01% 2039
2022
Q4
$7.98M Buy
118,108
+18,090
+18% +$1.66M ﹤0.01% 1981
2022
Q3
$12.5M Buy
100,018
+34,851
+53% +$4.15M ﹤0.01% 1690
2022
Q2
$6.2M Sell
65,167
-9,812
-13% -$1.2M ﹤0.01% 2096
2022
Q1
$12.1M Buy
74,979
+712
+1% +$139K ﹤0.01% 1839
2021
Q4
$24.7M Buy
+74,267
New +$35.3M 0.01% 1409

Other funds holding DNA